Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.48
-0.45 (-1.41%)
Oct 30, 2026, 4:00 PM EST - Market closed
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.7 billion as of October 30, 2026. It is the 7,222nd most valuable company in the world and the 1,880th biggest in the United States. Its market cap has increased by 23.85% in one year.
Market Cap
1.70B
Enterprise Value
1.26B
1-Year Change
23.85%
Global Rank
Country Rank
#1,880 United States
Category
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.70B, an increase of 147.77%. That is a compound annual growth rate of 68.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.70B | -14.84% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Braveheart Bio | 1.76B |
| Intellia Therapeutics | 1.75B |
| uniQure | 1.72B |
| Stoke Therapeutics | 1.70B |
| Nuvation Bio | 1.67B |
| Replimune Group | 1.67B |
| Kailera Therapeutics | 1.67B |
| Novavax | 1.66B |